Abbott Lodges New Zemplar Patent Suit Against Hospira
Abbott Laboratories sued generic-drug maker Hospira Inc. on Monday in Delaware federal court, claiming that Hospira infringed its patent by launching plans to produce paricalcitol, which Abbott markets as the kidney...To view the full article, register now.
Already a subscriber? Click here to view full article